Evidence‐based path to newborn screening for duchenne muscular dystrophy
2012 · Annals of Neurology · 790 citations
https://doi.org/10.1002/ana.23528
K
Kevin M. Flanigan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
365
Papers
15.9K
Citations
68
h-index
159
i10-index
Kevin M. Flanigan is an academic researcher from Nationwide Children's Hospital. The author has contributed to research in topics: Muscle Physiology and Disorders & Neurogenetic and Muscular Disorders Research & RNA Research and Splicing. The author has an h-index of 68, co-authored 311 publications.
ORCID: 0000-0001-6440-3376Papers by this author
worksThe TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
2015 · Human Mutation · 733 citations
https://doi.org/10.1002/humu.22758
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy
2016 · The American Journal of Human Genetics · 72 citations
https://doi.org/10.1016/j.ajhg.2016.08.023
Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial
2013 · Neuromuscular Disorders · 69 citations
https://doi.org/10.1016/j.nmd.2013.09.004
Clinical and Diagnostic Features of Delayed Hypoxic Leukoencephalopathy
2008 · Journal of Neuropsychiatry · 51 citations
https://doi.org/10.1176/jnp.2008.20.4.473
A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design
2016 · Molecular Genetics and Metabolism · 50 citations
https://doi.org/10.1016/j.ymgme.2016.08.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat